Gert van der Hoek
In Memoriam - Editor, Senior Moderator
JANUARY 27, 2020
As a novel coronavirus spreads through China and rattles the rest of theworld, the pharmaceutical industry is on guard over the adequacy of its global supply chain.
Over the past decade, China has become a bigger player in the market for active pharmaceutical ingredients, which are the building blocks found in each drug. China is now home to 13% of all facilities that make ingredients for medicines that are sold in the U.S., according to the Food and Drug Administration. By comparison, 28% of such facilities are in the U.S. and 26% are in the European Union.
? Roughly 80% of active ingredients used by commercial sources to produce finished medicines come from China. ?
As a novel coronavirus spreads through China and rattles the rest of theworld, the pharmaceutical industry is on guard over the adequacy of its global supply chain.
Over the past decade, China has become a bigger player in the market for active pharmaceutical ingredients, which are the building blocks found in each drug. China is now home to 13% of all facilities that make ingredients for medicines that are sold in the U.S., according to the Food and Drug Administration. By comparison, 28% of such facilities are in the U.S. and 26% are in the European Union.
? Roughly 80% of active ingredients used by commercial sources to produce finished medicines come from China. ?